BMO Capital Maintains Outperform on Houlihan Lokey, Lowers Price Target to $145

Benzinga Newsdesk www.benzinga.com Negative 92.1%

Neg 92.1% Neu 0% Pos 0%

BMO Capital analyst Brennan Hawken maintains Houlihan Lokey (NYSE:HLI) with a Outperform and lowers the price target from $160 to $145.